Condition: Pancreatic Adenocarcinoma Advanced or Metastatic · Sponsor: Gruppo Oncologico del Nord-Ovest
PANThEON is a randomized, open-label, multicenter phase III trial aimed at comparing the switch maintenance with gemcitabine plus nab-paclitaxel (ARM B) versus mFOLFIRINOX continuation (ARM A) in terms of overall survival (OS) in patients with unresectable LAD or mPDAC without disease progression following 3 months of induction mFOLFIRINOX triplet chemotherapy.
This description comes directly from the study's public registry record.
Monica Niger, MD · +3902 2390 2919 · monica.niger@istitutotumori.mi.it
Always discuss trial participation with your own doctor first.
| Centro Di Riferimento Oncologico Di Aviano | Aviano, Italy, Italy | Recruiting |
| University Hospital Consorziale Policlinico | Bari, Italy, Italy | Not Yet Recruiting |
| Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia | Brescia, Italy, Italy | Not Yet Recruiting |
| ASST Ospedale Maggiore di Crema | Crema, Italy, Italy | Recruiting |
| Azienda Socio Sanitaria Territoriale Di Cremona | Cremona, Italy, Italy | Not Yet Recruiting |
| Careggi University Hospital | Florence, Italy, Italy | Not Yet Recruiting |
| IRCCS Ospedale Policlinico San Martino | Genoa, Italy, Italy | Not Yet Recruiting |
| Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori IRST S.r.l. | Meldola, Italy, Italy | Recruiting |
| Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico | Milan, Italy, Italy | Not Yet Recruiting |
| Fondazione IRCCS Istituto Nazionale dei Tumori | Milan, Italy, Italy | Not Yet Recruiting |
| Istituto Europeo Di Oncologia S.r.l. | Milan, Italy, Italy | Not Yet Recruiting |
| ASST Grande Ospedale Metropolitano Niguarda | Milan, Italy, Italy | Recruiting |
+ 16 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06897644